An odor-specific threshold deficit implicates abnormal cAMP signaling in youths at clinical risk for psychosis

Schizophrenia Research

Volumn 138, Issue 2-3, 2012, Pages 280-284

  Kamath, Vidyulata ^a   Moberg, Paul J ^a   Calkins, Monica E ^a   Borgmann Winter, Karin ^a,c   Conroy, Catherine G ^a   Gur, Raquel E ^a,b   Kohler, Christian G ^a   Turetsky, Bruce I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Adenosine cyclase; CAMP; DISC1; Schizophrenia prodrome; Ultra high risk

Indexed keywords

CYCLIC AMP;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPOSMIA; INTRACELLULAR SIGNALING; MALE; MOLECULAR PATHOLOGY; OLFACTORY DISCRIMINATION; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SENSORY ANALYSIS; SENSORY EVALUATION; SMELLING DISORDER;

ADOLESCENT; ALDEHYDES; CELL COMMUNICATION; CYCLIC AMP; CYCLOHEXENES; FEMALE; HUMANS; MALE; NITRILES; ODORS; OLFACTION DISORDERS; OLFACTORY PERCEPTION; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIA; SENSORY THRESHOLDS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84862137814     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2012.03.029     Document Type: Article

References (41)

1. Andreasen, N.C., Wilcox, M.A., Ho, B.C., Epping, E., Ziebell, S., Zeien, E., et al., in press. Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. Mol. Psychiatry. doi:. doi:10.1038/mp.2011.108.
2. Borgmann-Winter K.E., Rawson N.E., Wang H.Y., Wang H., Macdonald M.L., Ozdener M.H., et al. Human olfactory epithelial cells generated in vitro express diverse neuronal characteristics. Neuroscience 2009, 158(2):642-653.
3. Brewer W.J., Wood S.J., McGorry P.D., Francey S.M., Phillips L.J., Yung A.R., et al. Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am. J. Psychiatry 2003, 160(10):1790-1794.
4. Carlyle B.C., Mackie S., Christie S., Millar J.K., Porteous D.J. Co-ordinated action of disc1, pde4b and gsk3beta in modulation of cAMP signalling. Mol. Psychiatry 2011, 16(7):693-694.
5. Chesler A.T., Zou D.J., Le Pichon C.E., Peterlin Z.A., Matthews G.A., Pei X., et al. A g protein/cAMP signal cascade is required for axonal convergence into olfactory glomeruli. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(3):1039-1044.
6. Col J.A., Matsuo T., Storm D.R., Rodriguez I. Adenylyl cyclase-dependent axonal targeting in the olfactory system. Development 2007, 134(13):2481-2489.
7. Doty R.L., Kreiss D.S., Frye R.E. Human odor intensity perception: correlation with frog epithelial adenylate cyclase activity and transepithelial voltage response. Brain Res. 1990, 527(1):130-134.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV - Patient Edition (SCID-P, version 2.0) 1996, New York State Psychiatric Institute, New York.
9. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders 1997, American Psychiatry Press, Washington, DC.
10. 2+]I by inhibitors of protein kinases a and c in rat and human olfactory receptor neurons. Neuroscience 2000, 98(1):181-189.
11. Gomez G., Rawson N.E., Hahn C.G., Michaels R., Restrepo D. Characteristics of odorant elicited calcium changes in cultured human olfactory neurons. J. Neurosci. Res. 2000, 62(5):737-749.
12. Hahn C.G., Gomez G., Restrepo D., Friedman E., Josiassen R., Pribitkin E.A., et al. Aberrant intracellular calcium signaling in olfactory neurons from patients with bipolar disorder. Am. J. Psychiatry 2005, 162(3):616-618.
13. Hahn C.G., Han L.Y., Rawson N.E., Mirza N., Borgmann-Winter K., Lenox R.H., et al. In vivo and in vitro neurogenesis in human olfactory epithelium. J. Comp. Neurol. 2005, 483(2):154-163.
14. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10:40-68.
15. Hummel T., Sekinger B., Wolf S.R., Pauli E., Kobal G. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem. Senses 1997, 22(1):39-52.
16. Imai T., Suzuki M., Sakano H. Odorant receptor-derived cAMP signals direct axonal targeting. Science 2006, 314(5799):657-661.
17. Kamath, V., Turetsky, B.I., Calkins, M.E., Kohler, C.G., Conroy, C.G., Borgmann-Winter, K., et al., in press. Olfactory processing in schizophrenia, non-ill first-degree family members, and young people at-risk for psychosis. World J. Biol. Psychiatry. doi:. doi:10.3109/15622975.2011.615862.
18. Keshavan M.S., Vora A., Montrose D., Diwadkar V.A., Sweeney J. Olfactory identification in young relatives at risk for schizophrenia. Acta Neuropsychiatr. 2009, 3:121-124.
19. Kobal G., Hummel T., Sekinger B., Barz S., Roscher S., Wolf S. "Sniffin' sticks": screening of olfactory performance. Rhinology 1996, 34(4):222-226.
20. Lowe G., Nakamura T., Gold G.H. Adenylate cyclase mediates olfactory transduction for a wide variety of odorants. Proc. Natl. Acad. Sci. U S A 1989, 86(14):5641-5645.
21. McGlashan T.H., Miller T.J., Woods S.W., Hoffman R.E., Davidson L. Instrument for the assessment of prodromal symptoms and states. Early Intervention in Psychotic Disorders 2001, 135-150. Kluwer Academic Publishers, Dordrecht. T.J. Miller (Ed.).
22. McGlashan T.H., Miller T.J., Woods S.W., Rosen J.L., Hoffman R.E., Davidson L. Structured Interview for Prodromal Syndromes 2003, version 4.0., Prime Clinic Yale School of Medicine, New Haven, CT.
23. Millar J.K., Pickard B.S., Mackie S., James R., Christie S., Buchanan S.R., et al. Disc1 and pde4b are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 2005, 310(5751):1187-1191.
24. Miller T.J., McGlashan T.H., Woods S.W., Stein K., Driesen N., Corcoran C.M., et al. Symptom assessment in schizophrenic prodromal states. Psychiatr. Q. 1999, 70(4):273-287.
25. Miller T.J., McGlashan T.H., Rosen J.L., Cadenhead K., Cannon T., Ventura J., et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull. 2003, 29(4):703-715.
26. Murdoch H., Mackie S., Collins D.M., Hill E.V., Bolger G.B., Klussmann E., et al. Isoform-selective susceptibility of disc1/phosphodiesterase-4 complexes to dissociation by elevated intracellular cAMP levels. J. Neurosci. 2007, 27(35):9513-9524.
27. NIMH Genetics Initiative Family Interview for Genetic Studies (FIGS) 1992, National Institute of Mental Health, Rockville, MD.
28. Nurnberger J.I., Blehar M.C., Kaufmann C.A., York-Cooler C., Simpson S.G., Harkavy-Friedman J., et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH genetics initiative. Arch. Gen. Psychiatry 1994, 51(11):849-859. (discussion 863-844).
29. Pepe M.S., Cai T., Longton G. Combining predictors for classification using the area under the receiver operating characteristic curve. Biometrics 2006, 62(1):221-229.
30. Sklar P.B., Anholt R.R., Snyder S.H. The odorant-sensitive adenylate cyclase of olfactory receptor cells: differential stimulation by distinct classes of odorants. J. Biol. Chem. 1986, 261(33):15538-15543.
31. Thomson P.A., Wray N.R., Millar J.K., Evans K.L., Le Hellard S., Condie A., et al. Association between the trax/disc locus and both bipolar disorder and schizophrenia in the Scottish population. Mol. Psychiatry 2005, 10:657-668.
32. Turetsky B.I., Moberg P.J. An odor-specific threshold deficit implicates abnormal intracellular cyclic AMP signaling in schizophrenia. Am. J. Psychiatry 2009, 166(2):226-233.
33. Turetsky B.I., Moberg P.J., Yousem D.M., Doty R.L., Arnold S.E., Gur R.E. Reduced olfactory bulb volume in patients with schizophrenia. Am. J. Psychiatry 2000, 157(5):828-830.
34. Turetsky B.I., Moberg P.J., Roalf D.R., Arnold S.E., Gur R.E. Decrements in volume of anterior ventromedial temporal lobe and olfactory dysfunction in schizophrenia. Arch. Gen. Psychiatry 2003, 60(12):1193-1200.
35. Turetsky B.I., Glass C.A., Abbazia J., Kohler C.G., Gur R.E., Moberg P.J. Reduced posterior nasal cavity volume: a gender-specific neurodevelopmental abnormality in schizophrenia. Schizophr. Res. 2007, 93(1-3):237-244.
36. Turetsky B.I., Hahn C.G., Borgmann-Winter K., Moberg P.J. Scents and nonsense: olfactory dysfunction in schizophrenia. Schizophr. Bull. 2009, 35(6):1117-1131.
37. Vacic V., McCarthy S., Malhotra D., Murray F., Chou H.H., Peoples A., et al. Duplications of the neuropeptide receptor gene vipr2 confer significant risk for schizophrenia. Nature 2011, 471(7339):499-503.
38. Wilkinson G.S. Wide Range Achievement Test (WRAT3) Administration Manual 1993, Wide Range, Inc., Wilmington, DE.
39. Woodberry K.A., Seidman L.J., Giuliano A.J., Verdi M.B., Cook W.L., McFarlane W.R. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr. Res. 2010, 123(2-3):188-198.
40. Zou D.J., Chesler A.T., Le Pichon C.E., Kuznetsov A., Pei X., Hwang E.L., et al. Absence of adenylyl cyclase 3 perturbs peripheral olfactory projections in mice. J. Neurosci. 2007, 27(25):6675-6683.
41. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993, 39(4):561-577.